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Abstract
Background: Stromal fibroblasts are important determinants of tumor cell behavior. They act to condition the tumor
microenvironment, influence tumor growth, support tumor angiogenesis and affect tumor metastasis. Heparan sulfate
proteoglycans, present both on tumor and stromal cells, interact with a large number of ligands including growth factors,
their receptors, and structural components of the extracellular matrix. Being ubiquitously expressed in the tumor
microenvironment heparan sulfate proteoglycans are candidates for playing central roles in tumor-stroma interactions. The
objective of this work was to investigate the role of heparan sulfate expressed by stromal fibroblasts in modulating the
growth of tumor cells and in controlling the interstitial fluid pressure in a 3-D model.
Methodology/Principal Findings: We generated spheroids composed of fibroblasts alone, or composite spheroids,
composed of fibroblasts and tumor cells. Here we show that stromal fibroblasts with a mutation in the heparan sulfate
elongating enzyme Ext1 and thus a low heparan sulfate content, formed composite fibroblast/tumor cell spheroids with a
significant lower interstitial fluid pressure than corresponding wild-type fibroblast/tumor cell composite spheroids.
Furthermore, immunohistochemistry of composite spheroids revealed that the cells segregated, so that after 6 days in
culture, the wild-type fibroblasts formed an inner core and the tumor cells an outer layer of cells. For composite spheroids
containing Ext1-mutated fibroblasts this segregation was less obvious, indicating impaired cell migration. Analysis of tumor
cells expressing the firefly luciferase gene revealed that the changes in tumor cell migration in mutant fibroblast/tumor cell
composite spheroids coincided with a lower proliferation rate.
Conclusions/Significance: This is the first demonstration that stromal Ext1-levels modulate tumor cell proliferation and
affect the interstitial fluid pressure in a 3-D spheroid model. Learning how structural changes in stromal heparan sulfate
influence tumor cells is essential for our understanding how non-malignant cells of the tumor microenvironment influence
tumor cell progression.
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Introduction
Cancer can be described as aberrations of normal tissue
development [1,2]. In recent years it has become increasingly
recognized that the growth and malignancy of a tumor is largely
dictated by the surrounding microenvironment, i.e. the tumor
stroma [3,4]. Among the major cell types that seem to be
important for conditioning the microenvironment are the fibro-
blasts, which in tumors have been referred to by a number of
names, but are now commonly called cancer-associated fibroblasts
(CAFs) [5]. The normal stroma is composed of orderly structured
mesenchymal cells (including adult tissue mesenchymal stem cells
and fibroblasts) and extracellular substances, vascular and
lymphatic networks, and minimal immune cell infiltrate. Fibro-
blasts are the predominant cells in the stroma and are responsible
for the synthesis, deposition and remodeling of the extracellular
matrix (ECM) as well as the production of growth factors,
cytokines and ECM-degrading proteases [6,7]. Cells are anchored
in the ECM via specific receptors belonging to different
superfamilies, including members of the integrin and heparan
sulfate (HS) proteoglycan (PG) families [8,9]. The ECM, in
addition to its supportive structural role, acts as a reservoir for
growth factors, guides cell migration, influences cell signaling, cell
growth, cell differentiation and direct angiogenesis [8].
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Heparan sulfate proteoglycans (HSPGs) are ubiquitously
expressed on cell surfaces and in the ECM. They interact with a
large number of ligands including growth factors, their receptors,
and also structural components of the ECM. HSPGs, expressed on
both tumor cells and in surrounding tissues, may thus exhibit
pivotal functions in tumor growth, tumor cell adhesion and
metastasis [10]. The specific roles of HSPGs within the tumor
microenvironment may be manifold. Secreted HSPGs function as
structural constituent of the ECM and can trap and store growth
factors within the ECM. HSPGs on the cell surface of both stromal
fibroblasts and tumor cells, act as co-receptors in cytokine and
growth factor signaling and can thereby regulate cell proliferation,
matrix production, cell migration and the invasive properties of
tumor cells [10]. They may also serve as a reservoir of bound
growth factors that are released by metalloproteinase-mediated
matrix degradation [11].
The functions of HSPGs depend on noncovalent binding of its
negatively charged polysaccharide chains with secreted proteins in
the extracellular matrix and with membrane bound receptors.
Protein binding to HS most likely depends on the specific
structural features within the HS chains [12,13] as well as the
chain length [14]. There is a multitude of reports on alterations in
HSPG expression and structure in tumor cells as compared to
corresponding normal cells, which may affect the efficiency of
growth factor stimulation of tumor cells [10,11,15,16,17,18].
However, limited information is available on how structural
changes in HS chains on cells in the tumor microenvironment
affect tumor growth and invasiveness. Tumor progression depends
on crosstalk between tumor cells and stromal fibroblasts and it has
lately become evident that the stromal-derived HSPG syndecan-1
is important in signaling between stromal fibroblasts and
carcinoma cells [15,19]. Changes in sulfation pattern or chain
length of stromal-derived HS will potentially lead to altered affinity
for growth factors and cytokines, and consequently alter the
biological activities of these factors during tumorigenesis.
The interstitial connective tissue provides the route of transport
for fluids and solutes from plasma to tissues. Interstitial fluid
pressure (Pif) is important in controlling the interstitial fluid volume
and is regulated through interactions between integrins on stromal
cells and ECM-molecules [20]. Under normal conditions, Pif in
skin is approximately -1 mmHg [21]. Tumor Pif is often elevated
compared to the surrounding tissue, often as high as 20 mmHg
that is commonly described as a ‘‘functional barrier’’ for delivery
of cytostatic agents across the microvascular barrier [20,22]. Part
of this elevated Pif is generated by the circulatory system since the
elevated Pif will fall by about 1/3 when the circulation is arrested
[23]. However, although some information is available about the
contribution from individual ECM components in generating the
elevated Pif in tumors, much remains to be investigated. Thus,
disruption of collagen fiber assembly in fibromodulin knockout
mice results in a looser collagen network and lower Pif [24].
Furthermore, inhibition of VEGF [25], PDGF-BB [26] and TGF-
b [27] results in lower and less dense ECM and a lower tumor-Pif.
In addition, cell surface HSPGs have, with contributions from
integrins, been suggested to be mechanosensors for sensing
interstitial flow in a 3-dimensional (3D) microenvironment [28].
However, the contribution of stromal HS chains for creating
interstitial fluid pressure in different tissues is currently unclear.
The aim of the present study was to extend these studies of the
role of the HSPG in tumor stroma interactions by using a 3-D
spheroid system to investigate the contribution of stromal HS
chains to tumor cell-fibroblast interactions and, the Pif, in this
model system.
Results
Cell Surface HS Expression by Tumor Cells and
Fibroblasts
The relative amounts of cell surface HS expressed by wild-type
fibroblast, Ext1Gt/Gt fibroblasts, the A549 non-small cell lung
adenocarcinoma cells and the large cell lung carcinoma NCI-
H460 (H460) were determined by flow cytometry using the 10E4
antibody. The 10E4 antibody, specific for HS chains, recognizes
sulfated regions within HS chains [29], and is commonly used to
trace HSPGs. In agreement with our previous results, wild-type
(wt) fibroblasts stained strongly with 10E4 antibody whereas the
Ext1Gt/Gt cells, that have very short HS chains, stained poorly with
the antibody [14]. The A549 cells showed an intermediate staining
indicating a cell surface HS expression in-between the two
different fibroblast cell lines, whereas the HS expression of H460
cells was similar to that observed for wild-type fibroblasts (Fig. 1).
Spheroid Formation by Tumor Cells and Fibroblasts
We first evaluated the ability of our genetically different
fibroblasts and three human tumor cell lines, A549, H460 and
the cervical adenocarcinoma HeLa, to grow as multicellular
spheroids using the ‘‘hanging drop’’ method. Spheroid formation
by the hanging drop method is a gravity driven ‘‘microtissue’’
formation and spheroids form homogenous spheroids of similar
sizes with identical number of starting cells [30,31]. When cells
collect at the base of the hanging drop spheroid formation occur
via a complex pattern of interacting cell surface molecules such as
b1 integrin and/or cadherin mediated cell-cell or cell-ECM
interactions [32]. Finally, compact 3D spheroids are produced by
cellular contraction of the matrix [33]. Both Ext1Gt/Gt and wild-
type fibroblasts spontaneously formed regularly shaped spheroids
after 4 days without any significant differences in size (Fig. 2).
None of the human tumor cell lines tested formed spheroids by
themselves but instead formed unevenly shaped loose sheet-like
cellular aggregates (Table 1, and Fig. 2).
To study the behavior of our mouse embryonic fibroblasts when
in contact with tumor cells we next generated composite spheroids.
To determine the fibroblast to tumor cell ratio needed to achieve
tightly packed rounded spheroids we performed a series of tumor
spheroid cultures with different proportions of fibroblasts. The 1:1
ratio of fibroblasts to tumor cells enabled spheroid formation but
the spheroids were loose aggregates that easily dispersed. Tighter
Figure 1. Cell surface expression of HS on wild-type fibro-
blasts, Ext1Gt/Gt fibroblasts, A549 and H460 tumor cells.
Representative flow cytometry fluorescence histograms of 10E4
antibody binding to A549 and H460 tumor cells (black profiles), wild-
type fibroblasts (black profile) and Ext1Gt/Gt fibroblasts (unfilled black
curve). Controls represent cells treated only with the secondary
antibody (gray profiles).
doi:10.1371/journal.pone.0041334.g001
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rounded spheroids were formed with a fibroblast to tumor cell
ratio of 8:2 or 9:1 in the seeding mixture (Table 1) indicating that
fibroblasts stabilized the spheroids. Based on these results and
published data demonstrating that in desmoplastic tumors
fibroblasts can occupy more than 90% of the tumor mass
[34,35], the 9:1 ratio was used in further experiments.
Immunohistochemical staining of spheroid-sections using anti-
bodies to mouse b1 integrin (specific for fibroblasts) and to human
keratins (specific for epithelial cells) was used to assess the impact
of the Ext1Gt/Gt mutation on tumor cell-fibroblast interactions
(Fig. 3). Surprisingly, quite dramatic effects of the Ext1Gt/Gt
mutation were observed in 4- and 6-days old composite spheroids.
In Ext1Gt/Gt/tumor cell composite spheroids the tumor cells were
scattered inside the spheroids with a tendency to migrate out to the
periphery of the spheroids (Fig. 3). By contrast, for wt/tumor cell
composite spheroids, the tumor cells started to migrate out to the
periphery of the spheroids at day 4 and at day 6 they completely
surrounded the fibroblasts (Fig. 3). Similar results as shown in
Figure 3 (fibroblast to A549 cells in 9 to 1 ratio), were observed
Figure 2. Morphology of single cell type spheroids and composite spheroids. Representative phase contrast images of multicellular
spheroids generated by the hanging drop method after 4 days in culture. MEFs, mouse embryonic fibroblasts. Wild-type fibroblast spheroids, Ext1Gt/Gt
spheroids and composite spheroids, magnification 10X; tumor cell (A549, H460 and HeLa) spheroids, magnification 4X: all size bars = 100 mm.
doi:10.1371/journal.pone.0041334.g002
Table 1. Phenotypes of tumor cell lines grown as single cell
type tumor spheroids and fibroblast/tumor composite
spheroid using the hanging drop method.
Cell line Tumor type Spheroid formation
100% 50% 10%
A549 Lung adenocarcinoma No Irregular, loose aggregates Yes
H460 Lung carcinoma No Irregular, loose aggregates Yes
HeLa Cervical
adenocarcinoma
No Rounded flat, loose
aggregates
Yes
Spheroids were grown from tumor cells alone (100%), or mixed with different
proportions of wild type mouse embryonic fibroblasts. 50% and 10% refer to
the amount of tumor cells in the composite spheroids. Spheroid morphology
was assessed and photographed under a phase contrast microscope using a
Nikon D3000 digital camera 4 and 6 days after seeding.
doi:10.1371/journal.pone.0041334.t001
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also for composite spheroids generated by mixing fibroblasts to
A549 cells in 8 to 2 ratio (data not shown). Furthermore, as evident
from figure 3, at both 4 and 6 days, all Ext1Gt/Gt containing
spheroids appeared larger than corresponding wt-containing
spheroids. This is unlikely to be due to increased fibroblast cell
proliferation as the Ext1Gt/Gt cells proliferate at a slower rate as
compared to wt cells and attach poorly to collagen I [14], rather
suggesting that the Ext1Gt/Gt cells form looser cell-matrix contacts
and/or that tumor cell proliferation is affected.
Tumor cell proliferation within tumor cell/ fibroblast
composite spheroids
The staining pattern of composite spheroids indicated that there
were fewer tumor cells in Ext1Gt/Gt-containing spheroids as
compared to wild type fibroblast-containing composite spheroids.
As the same number of tumor cells was used in the seeding
mixtures we investigated if this was due to a difference in
proliferation rate of the tumor cells. To assess tumor cell
proliferation in composite spheroids, we used A549 and H460
expressing the firefly luciferase (A549-Luc and H460-luc, respec-
tively). In this assay, the luciferase activity is directly related to the
proliferation rate/the number of tumor cells. Our data showed
that proliferation of both A549 and H460 cells were clearly
attenuated in Ext1Gt/Gt/tumor cell composite spheroids as com-
pared to wt/tumor cell spheroids (Fig. 4).
Size and Interstitial Fluid Pressure in Spheroids Formed
by Tumor Cells and Fibroblasts
The interstitial fluid pressures (Pif) of fibroblast spheroids seeded
on soft agar plates were investigated in 2- and 4-day old spheroids.
Ext1Gt/Gt fibroblasts had a bias to form larger spheroids than the
wild-type fibroblast when grown on agar plates, although the
changes in size were not statistically significant (Fig. 5A). It has
previously been shown that larger spheroids have a tendency to
have higher Pif than smaller spheroids [36]. Therefore, to ascertain
that any changes in Pif between spheroids generated from wt or
Ext1Gt/Gt fibroblasts were not due to size differences, similar size
spheroids were used for Pif-measurements. The Ext1
Gt/Gt spheroid-
Pif was significantly lower than that of wt spheroids both at day 2
and day 4 (Fig. 5B) further supporting the concept that Ext1Gt/Gt
fibroblasts formed less densely packed spheroids.
The Pif in composite spheroids, Ext1
Gt/Gt/A549 and wt/A549,
were measured in 4-day old spheroids. In contrast to what was
observed for pure fibroblast spheroids and Ext1Gt/Gt/A549
spheroids, which had a homogenous Pif throughout the spheroid,
the Pif of wt/A549 spheroids varied greatly with the depth of
measurement (Fig. 5D). A significant higher Pif was observed in the
center of the wt/A549 composite spheroids than in the periphery.
The average Pif just under the surface was 0.7 mm Hg whereas it
in the center was 6.0 mm Hg. The Ext1Gt/Gt/A549 composite
spheroids had an average Pif of 1.5 mm Hg and 2.1 mm Hg under
the surface and in the center, respectively. Although there was a
tendency of a lower peripheral vs. central Pif in Ext1
Gt/Gt/A549
composite spheroids, the difference was only statistically significant
for wt/A549 composite spheroids as indicated in Fig. 5D.
The Ext1-dependend influence on the Pif was not restricted to a
single tumor cell line or spheroid growth condition, as similar
difference in central Pif was observed also for H460 containing
composite spheroids grown as hanging drops (Fig. 5F).
Collagen Gel Invasion
We have previously shown that Ext1Gt/Gt fibroblasts have
impaired interaction with collagen I, resulting in decreased cell
adhesion and reduced ability to reorganize collagen gels [14]. We
therefore examined spheroid cell invasion into collagen type I gels.
Spheroids were plated on polymerized collagen I gels and the cells
migrating out of the spheroids and into the collagen matrix, were
monitored by phase contrast microscopy. The migration rate of
the Ext1Gt/Gt cells out from the spheroid into the collagen gel was
Figure 3. Organization of tumor cells and stromal cells in
composite spheroids. Composite spheroids of mouse fibroblasts and
human tumor cells (as indicated) generated by the hanging drop
method, were double-stained with antibodies towards human cytoker-
atin 7 or 18 (red) and mouse b1 integrin (green) at day 4 and day 6.
Magnification: 10X, size bars = 100 mm.Tumor cell proliferation within
tumor cell/fibroblast composite spheroids.
doi:10.1371/journal.pone.0041334.g003
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significantly higher than that of the wild-type spheroid fibroblasts
(Fig. 6). The Ext1Gt/Gt cells started to migrate out from the
spheroid almost immediately after seeding and 24 hours after
seeding, all Ext1Gt/Gt fibroblasts had migrated into the gel, and the
three-dimensional spheroid structure was not longer obvious
(Fig. 6, right panel). In contrast, the outgrowth of the wild-type
fibroblasts was slow and after 24 hours most of the spheroid
structures were still visible (Fig. 6, left panel).
After prolonged incubation also the wild-type fibroblast
completely migrated out of the spheroids and into the collagen
matrix and effectively induced collagen gel contraction. One week
after seeding the wild-type fibroblasts had contracted the collagen
gels to approximately 10% of the initial diameter (data not shown).
In contrast, the Ext1Gt/Gt cells are poor in stimulating collagen gel
contraction and, in agreement with previous data, no significant
contraction of collagen lattices could be detected after Ext1Gt/Gt
cell invasion into collagen gels [14].
In contrast, no distinct cell migration out of the spheroids into
the collagen gel was observed with Ext1Gt/Gt/A549 and wt/A549
composite spheroids. Although some cells started to migrate out of
the spheroids within three hours after plating, the spheroids
disintegrated and after 24 hours the collagen gels were covered
with dispersed cellular aggregates (Fig. S1). One possible
explanation for this effect may be the poor spheroidicity of the
A549 cells alone, consistent with the previously reported
dependence of tumor cells to form compact spheroids for invasion
in 3-D collagen I matrices [33]. In addition, considering the fact
that the tumor cells occupy the periphery of the composite
spheroids, the tumor cell may act as a barrier to fibroblast
migration.
Discussion
With the aim to elucidate the role of fibroblast HS chains for
stroma-tumor cell interactions and interstitial fluid pressure, we
employed a 3-D spheroid tumor cell/fibroblast co-culture method,
believed to mimic the initial avascular state of solid tumors.
Moreover, results of previous studies suggest that, during spheroid
formation, the fibroblasts undergo activation and acquire a
phenotype, which resembles that of activated fibroblasts in tumor
stroma [37].
We have previously reported that Ext1Gt/Gt fibroblasts exhibit
short sulfated HS chains [38] and as a consequence these cells
have a reduced capacity to adhere to and to remodel collagen I,
although they express the collagen binding integrins a1, a2 and
a11 at similar levels as the wild-type fibroblasts [14]. Immuno-
histochemical characterization of the composite spheroids clearly
showed a difference in distribution of tumor cells and fibroblasts.
The tumor cells in wt/tumor cell composite spheroids migrated
out to the periphery and at day 6 completely surrounded the
fibroblasts. In contrast, the tumor cells mixed with Ext1Gt/Gt cells
showed a much slower rate of migration and were still intermixed
with the fibroblasts also after 6 days in culture. Tumor cell
proliferation was clearly attenuated in composite spheroids
containing Ext1Gt/Gt cells (Fig. 4). Taken together, these observa-
tions imply that the capacity of tumor associated fibroblasts to
attach to the surrounding ECM and, maybe also to each other,
affects the migration and proliferate properties of tumor cells.
Since the expression levels of different collagen binding integrins
are unchanged in Ext1Gt/Gt cells [14], this effect might be explained
by an altered activation status of the integrins and/or weakened
interactions between integrins and HS co-receptors. The wt/
tumor cell composite spheroids showed a clear border between the
center, containing fibroblasts, and the periphery containing tumor
cells, (Fig. 3) and the Pif differed significantly between the two
compartments. The Ext1Gt/Gt-containing composite spheroids, in
contrast, had a denser core of tumor cells at the center intermixed
with fibroblasts and as a consequence the Pif did not differ between
periphery and center. To the best of our knowledge, a role for HS
chains in regulating Pif has not been described before. The Pif in
normal tissues appears to be regulated by an integrin-mediated
fibroblast interaction with the ECM in parallel with growth factor
induced contractility of the cells [20,39,40]. In most solid tumors
the Pif is increased and thus an obstacle to cancer chemotherapy as
increased Pif counteracts capillary fluid filtration [20]. Thus, from
a functional point of view, our data suggest that in spheroids with
Ext1Gt/Gt mutated cells the ECM is less dense and has a higher
hydraulic conductivity resulting in a lower pressure gradient. Our
data strongly suggests that the HPSG affects the tumor stroma
properties as has previously been demonstrated for collagen
architecture [24] and the role of PDGF [26] and TGF-b [27].
Considering these facts, the lower interstitial fluid pressure
measurements in Ext1Gt/Gt containing spheroids and the increased
speed of migration out of the spheroids and into the collagen gels
of Ext1Gt/Gt cells (Fig. 6) are most probably not due to an increased
interaction with the collagen, but instead suggest that Ext1Gt/Gt
Figure 4. Tumor cell proliferation in composite spheroids.
Composite spheroids of mouse fibroblasts and human tumor cells
stably expressing the firefly luciferase gene (A549-Luc and H460-Luc)
were generated by the hanging drop method and assayed for luciferase
activity at the indicated time points. The figures show representative
results from one out of three independent experiments. At each time
point luminescence was measured from two separate spheroid
preparations performed in duplicate (A549-Luc) or triplicate (H460-
Luc). (**p,0.01,***p,0.001).
doi:10.1371/journal.pone.0041334.g004
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cells display an intermediate affinity between Ext1Gt/Gt cells and
collagen that is more optimal for cell migration. The molecular
mechanism for the Ext1-dependent attachment to collagen I
remains to be elucidated but, cell adhesion to ECM activate
several intracellular signaling pathways that regulate cell migration
through integrins and other cell surface receptors including
HSPGs. The Ext1Gt/Gt cells show impaired signaling response to
growth factor stimulation [14] and considering the emerging
concept of the HSPG-integrin cooperation in cell signaling
[16,41,42] the mutation may also influence the integrin-dependent
cell adhesion to collagen [9,43,44].
The interactions between cancer cells and their microenviron-
ment are central for tumor development [4,45]. The proportions
of different stromal cells and ECM differ widely between different
tumors. For example, in desmoplastic tumors, such as many
carcinomas of the breast, stomach and pancreas, the stromal
compartment may account for .80% of the tumor mass, whereas
in other tumors such as medullary carcinomas of the breast and
many lymphomas, stroma generally represents only a minimal
fraction [46]. There is no direct evidence for a close correlation
between the deposition of stroma and tumor malignancy. The
predominant cell type in the tumor stroma is the activated
fibroblast and in the tumor stroma microenvironment there is
paracrine signaling between the fibroblasts and the tumor cells. In
vitro studies of tumor cell behavior often include 2D (monolayer)
culture conditions, not taking into account that in vivo, tumor cells
grow within a 3D matrix [47,48]. Solid tumors in vivo often grow
with actively proliferating tumor cells close to blood vessels. In vivo,
the tumor cells and fibroblasts stay apart and the fibroblasts
surround the tumor cells [35,49] In addition to fibroblasts, solid
tumors contain endothelial cells and immunocompetent cells that
affect tumor cell growth and migration. Thus the tumor cell –
fibroblast arrangement observed in our spheroid model may
represent an avascular early stage of tumor development.
Enzymatic modification of tumor-derived HSPGs is an impor-
tant mechanism for regulation of HSPG function in cancer. These
modifications involve, release of the extracellular core protein by
sheddases (matrix metalloproteinases, MMPs) [15], cleavage of cell
associated HS chains by the heparanase enzyme or removal of
certain sulfates groups from the HS chains by the extracellular HS-
sulfatases reviewed in [10,11,16,17,18]. The molecular mechanism
by which stromal Ext1 levels, and the resulting changes in HS
Figure 5. Spheroid size and interstitial fluid pressure. The size and interstitial fluid pressure (Pif) were determined for 4-day-old spheroids
generated on agar plates (A-D) or by the hanging drop method (E and F). The spheroids are as indicated. (*p,0.05, **p,0.01, ***p,0.001).
doi:10.1371/journal.pone.0041334.g005
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chain length modulate tumor cell migration and Pif was beyond
the scope of this study but may involve, ECM assembly, growth
factor signaling and/or MMPs. It is important to emphasize that
the Ext1Gt/Gt mutation not only affect cell associated HSPGs,
involved in cell adhesion and cell signaling, but also the secreted
basement membrane HSPGs that are important modulators of
cancer growth and metastasis [50]. In addition, HSPGs, in
basement membranes and on cell surfaces, collaborate with other
Figure 6. Collagen invasion by fibroblast spheroids. Four-day-old spheroids, generated on agar plates, were seeded on top of polymerized
collagen type I (gels). Spheroid dissociation/fibroblast invasion into the collagen lattice was photographed under a light microscope at the indicated
time points. Size bars = 200 mm.
doi:10.1371/journal.pone.0041334.g006
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matrix components determining the structure and function of the
ECM [51,52]. MMPs are important in ECM remodeling
influencing cell adhesion, migration, differentiation and tissue
infiltration of tumor cells [53]. MMPs cleave ECM components
and ECM-associated molecules, including cell associated HSPGs,
thus liberating bioactive fragments and growth factors, all of which
influence cellular behavior. HS chains also directly interact with
several different MMPs which, depending on the particular MMPs
and HSPGs involved, can either increase or inhibit the catalytic
activity of the metalloprotease [54,55].
In conclusion, our results agree with previous studies demon-
strating a role for HSPGs for cell-ECM interactions. In addition,
using fibroblasts with a mutation in Ext1, we herein demonstrate a
central role of stromal HSPG for spheroid formation, the Pif and
tumor cell migration within these spheroids.
Materials and Methods
Cell Culture
Sv40-immortalized mouse embryonic fibroblast cell lines
derived from wild-type and Ext1 gene trapped
(Ext1Gt(pGT2TMpfs)064Wcs, Ext1Gt/Gt) embryonic day 11.5
mouse embryos were as described previously [38,56]. The human
non-small cell lung adenocarcinoma A549, the large cell lung
carcinoma NCI-H460 (H460) and the cervical adenocarcinoma
HeLa cell lines were from the American Type Culture Collection
(ATCC). Monolayer cultures and multicellular spheroids were
cultured in Dulbeccos modified Eagles medium (DMEM) with
Glutamax (Gibco) supplemented with 10% fetal bovine serum
(FBS), 100 units/ml of penicillin and 0.1 mg/ml of streptomycin
(all from PAA Laboratories).
Preparation and Culturing of Spheroids
Single cell type multicellular spheroids from wild-type and
Ext1Gt/Gt fibroblast and composite spheroids containing a mixture
of fibroblasts and tumor cells were prepared using the hanging
drop method [30,31]. Single cell suspension of fibroblasts or tumor
cells alone or a mixture of 10%, 50%, 80% or 90% fibroblasts
combined with 90%, 50%, 20% or 10% A549 cells were diluted to
16106 cells/ml. Twenty five microliters of the cell suspension
(2.56104 cells) were pipette onto the lid of a cell culture dish to
form one drop. Approximately 40 hanging drops were dispensed
on each lid that was then inverted and placed over a cell culture
dish containing DMEM for humidity and cultured under standard
conditions. H460 and HeLa cells were mixed with wild-type or
Ext1Gt/Gt fibroblasts in 1/1 and 9/1 ratios of fibroblasts to tumor
cells and cultured as described above.
In some experiments, as indicated in the text, single cell type
and composite spheroids were prepared using the liquid overlay
technique. Briefly, confluent monolayers were trypsinized, resus-
pended as single cells in supplemented DMEM, and 36106 cells
re-plated in a drop-wise fashion to 75-cm2 tissue culture dishes that
had been coated with 0.75% agar (Noble agar, Difco). Cells began
to form spheroids after one day and the media was renewed on
day two of sub culture.
Interstitial Fluid Pressure Measurements
For interstitial fluid pressure (Pif) measurements spheroids were
transferred to 10-cm cell culture dishes and left for 2 hours in
37uC. This allowed the spheroids to attach to the plastic without
starting to spread. Pif was measured using a micropuncture
technique [36]. Briefly, sharpened glass capillaries (tip diameter 3–
5 mm) filled with 0.5 M NaCl colored with Evans blue was
connected to a servo-controlled counter pressure system. The Pif
measured in the cell culture medium immediately outside the
spheroid was defined as its zero pressure. The glass capillary was
inserted into the spheroid with the help of a stereomicroscope
(Wild M5, Heerbrugg, Switzerland). Pif was recorded for 30
seconds and in order for a measurement to be accepted, the
following criteria had to be fulfilled: (1) feedback gain could be
changed without changing the pressure; (2) applying suction to the
glass capillary by the pump increased the resistance in the
capillary, i.e the capillary is open; and (3) zero pressure did not
change during the measurement. The size of the spheroids was
measured after each Pif recording using an eyepiece with a grid.
Spheroid Invasion into Collagen Gels
Collagen gels were made one day prior to seeding of the
spheroids, by mixing collagen type I (PureCol, Advanced
Biomatrix), Calcium- and Magnesium Free-Hanks Balanced Salt
solution (CMF-HBSS), 10 X Minimum Essential Medium (MEM)
(Gibco), NaHCO3, NaOH [57]. All solutions were kept on ice
before and during mixing. 500 ml aliquotes of the final gel solution,
containing 1 mg/ml collagen, was transferred to a 24-well plate
and were left to polymerize overnight in the cell culture incubator.
Spheroids were seeded on top of the collagen gels in 500 ml of
culture medium and photographed with phase contrast using a
Canon Powershot S50 digital camera mounted on a Leica DMIL
microscope at 0, 1.5, 3, 5 and 24 hours after plating, to monitor
the migration into the collagen lattices.
Immunofluorescence
Immunofluorescence staining was performed on cryosections of
4 and 6 days old spheroids generated using the hanging drop
technique. Sections with a thickness of 7 mm were fixed in acetone
for 10 minutes at 220uC and were then rehydrated in PBS
(3610 min). Unspecific binding sites were blocked with 10% goat
serum diluted in PBS for 1 hour at room temperature. Thereafter,
the sections were incubated with primary antibodies against mouse
b1 integrin (rat anti-mouse monoclonal, dilution 1:500, from
Millipore), human cytokeratin-7 (A549 and HeLa cells, rabbit
anti-human polyclonal, dilution 1:200, from Novus Biologicals)
and human cytokeratin-18 (NCI-H460 cells, rabbit anti-human
monoclonal, dilution 1:200, from Epitomics) for 1 hour at 37uC.
After two washing steps with PBS/0.05% Tween and an
additional washing step with PBS, the secondary antibodies were
applied. DyLight 488 AffiniPure Goat Anti-Rat IgG (H+L) (1:800,
Jackson ImmunoResearch,) was used as secondary antibody for b1
integrin and DyLight 549 AffiniPure Goat Anti-Rabbit IgG (H+L)
(1:800, Jackson ImmunoResearch,) was used for cytokeratin-7 and
cytokeratin-18. The sections were incubated with the secondary
antibody for 1 hour at RT. After two washing steps in PBS/0.05%
Tween, sections were mounted in Vectashield mounting media.
The stained sections were studied under a Zeiss Axioscope
fluorescence microscope and micrographs were acquired using a
digital AxioCam mRM camera (Zeiss).
Flow Cytometry
For flow cytometry analyses, cells were cultured to 80%
confluency in 6-well plates, harvested by trypsinization, transferred
to FACS tubes, washed three times in PBS and counted. For the
detection of cell surface-bound HS, 5.06105 cells were incubated
for 30 min at 4uC with 1:50 dilution of the primary antibody 10E4
(Seikagaku). After three washes with PBS, cells were incubated
with 1:75 dilution of the secondary antibody, an allophycocyanin
(APC) conjugated goat-anti-mouse IgG (Jackson ImmunoResearch
Laboratories, Inc.) and analyzed by flow cytometry using an
AccuriC6 system (Accuri Cytometers Inc.). Data analysis was
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performed using FlowJo software (Tree star, Inc.). Cells incubated
with the secondary antibody alone, served as negative controls.
Proliferation Assay
To determine tumor cell proliferation in composite spheroids,
A549 and H460 were stably transduced with a lentiviral
expression vector (pCDH-CMV-MCS-EF1-puro (CD510B-1)
HIV-based lentiviral vector, from System Biosciences expressing
luciferase-EGFP fusion protein (a kind gift from Dr. Jian Wang,
University of Bergen, Norway). Transduced cells (A549-Luc and
H460-Luc cell lines) were isolated via EGFP expression by flow
cytometry (BD FACSAria SORP, BD Biosciences, Franklin Lakes,
NJ, USA). Composite spheroids (Ext1Gt/Gt/A549-Luc, wt/A549-
Luc, Ext1Gt/Gt/H460-Luc and wt/H460-Luc, 9/1 ratio) were
prepared by the hanging drop method as described above.
Spheroids (20 drops for each preparation, 56105 cells/prepara-
tion) were collected from day 2 to day 6. Five hundred microliters
of the cell suspension (56105 cells) used for preparing the
spheroids was collected as the starting point for the assay (time
zero). Collected spheroids were frozen at 270uC until samples for
all time points were collected. Then, spheroids from each
preparation were solubilized in 100 ml lysis buffer (TropixH Lysis
Solution, from Applied Biosystems). A 20 ml-portion of each cell
lysate was transferred to microtiter plates to which 100 ml of
luciferase substrate (Luciferase Assay System, from Promega) was
added and luciferase luminescencewas measured using a Wallac
1420 VICROR3 Multilabel Counter (PerkinElmer). At each time
point, two separate spheroid preparations were measured in
duplicate or triplicate.
Statistical Analysis
To identify differences between groups for (n.2), a two-way
Anova with Bonferroni-Dunn correction for multiple comparisons,
was used. For comparisons where n = 2, the Mann-Whitney U-test
was applied. P,0.05 was considered statistical significant.
Supporting Information
Figure S1 Collagen invasion by composite spheroids.
Four-day-old fibroblast/A549 composite spheroids, generated on
agar plates, were seeded on top of polymerized collagen type I
(gels). Spheroid dissociation/fibroblast invasion into the collagen
lattice was photographed under a light microscope at the indicated
time points. Size bars = 200 mm.
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Acknowledgments
We thank Mona Grønning for excellent technical assistance.
Author Contributions
Conceived and designed the experiments: CÖ NL ÅL RKR DG MKG.
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